HDAC6 and central nervous system cancer: Based on the RNA-seq results of U251 cells and glioma clinical data (Figures 2, 4), we evaluated the expression levels of class I HDACs (HDAC1, 2, 3) and class IIb HDACs (HDAC6) in U251 cells treated with sodium butyrate.